Cellply vs Verdiva Bio

Cellply vs Verdiva Bio, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellply is on 52/100 and Verdiva Bio on 54/100.

CellplyDeepTech startup developing analytical tools for characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics.
Verdiva Bio logo
Verdiva BioClinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
Try Verdiva Bio

Where each one leads

Cellply

  • LinkedIn following: 9,134 against 6,379

Verdiva Bio

  • headcount: 74 against 25
  • funding raised: $170M against $7.2M

At a glance

MeasureCellplyVerdiva Bio
What it isDeepTech startup developing analytical tools for characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics.Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
CategoryBiotechnology, HealthTech, Artificial Intelligence, Medical DevicesBiotechnology, Pharmaceuticals, HealthTech, Medical Devices
Sells toBusiness modelB2BB2B
OfferingHardwareServices
Founded20132021
HeadquartersBologna, ItalySan Diego, United States
StatusActiveActive

Size, funding and growth

MeasureCellplyVerdiva Bio
Employees2574
Total funding$7.2M$170M
Latest roundFunding RoundSeries B
LinkedIn followers9,1346,379

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCellplyVerdiva Bio
StartupHub scoreOur 0-100 rating52/10054/100
Traction48/10059/100
Team60/100Not published
Community15/1008/100
Search visibility33/10034/100
Quality58/10068/100
Agent readinessHow well an AI agent can read and act on the siteNot publishedF (21/100)
Domain ratingLink authority, 0-100Not published23/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCellplyVerdiva Bio
HostingNot detectedSelf Managed
CMSNot detectedWordPress
FrameworksNot detectedJquery
AnalyticsNot detectedGoogle Analytics 4

Cellply vs Verdiva Bio: common questions

Which is better, Cellply or Verdiva Bio?

On our 0-100 score Verdiva Bio rates higher (54/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do Cellply and Verdiva Bio compare on the numbers?

Cellply leads on LinkedIn following (9,134 against 6,379). Verdiva Bio leads on headcount (74 against 25), funding raised ($170M against $7.2M).

Read the full Cellply review and pricing or the Verdiva Bio review and pricing. You can also browse other Cellply alternatives we track.